Cargando…

In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation

Biomedical implants remain an important clinical tool for restoring patient mobility and quality of life after trauma. While polymers are often used for devices, their degradation profile remains difficult to determine post-implantation. CT monitoring could be a powerful tool for in situ monitoring...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawelec, Kendell M., Hix, Jeremy M.L., Troia, Arianna, Kiupel, Matti, Shapiro, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634892/
https://www.ncbi.nlm.nih.gov/pubmed/37961412
http://dx.doi.org/10.1101/2023.10.26.564238
_version_ 1785146256621830144
author Pawelec, Kendell M.
Hix, Jeremy M.L.
Troia, Arianna
Kiupel, Matti
Shapiro, Erik
author_facet Pawelec, Kendell M.
Hix, Jeremy M.L.
Troia, Arianna
Kiupel, Matti
Shapiro, Erik
author_sort Pawelec, Kendell M.
collection PubMed
description Biomedical implants remain an important clinical tool for restoring patient mobility and quality of life after trauma. While polymers are often used for devices, their degradation profile remains difficult to determine post-implantation. CT monitoring could be a powerful tool for in situ monitoring of devices, but polymers require the introduction of radiopaque contrast agents, like nanoparticles, to be distinguishable from native tissue. As device function is mediated by the immune system, use of radiopaque nanoparticles for serial monitoring therefore requires a minimal impact on inflammatory response. Radiopaque polymer composites were produced by incorporating 0-20wt% TaO(x) nanoparticles into synthetic polymers: polycaprolactone (PCL) and poly(lactide-co-glycolide) (PLGA). In vitro inflammatory response to TaO(x) was determined by monitoring mouse bone marrow derived macrophages on composite films. Nanoparticle addition stimulated only a slight inflammatory reaction, namely increased TNFα secretion, mediated by changes to the polymer matrix properties. When devices (PLGA 50:50 + 20wt% TaO(x)) were implanted subcutaneously in a mouse model of chronic inflammation, no changes to device degradation were noted although macrophage number was increased over 12 weeks. Serial CT monitoring of devices post-implantation provided a detailed timeline of device structural collapse, with no burst release of the nanoparticles from the implant. Changes to the device were not significantly altered with monitoring, nor was the immune system ablated when checked via blood cell count and histology. Thus, polymer devices incorporating radiopaque TaO(x) NPs can be used for in situ CT monitoring, and can be readily combined with multiple medical imaging techniques, for a truly dynamic view biomaterials interaction with tissues throughout regeneration, paving the way for a more structured approach to biomedical device design.
format Online
Article
Text
id pubmed-10634892
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-106348922023-11-13 In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation Pawelec, Kendell M. Hix, Jeremy M.L. Troia, Arianna Kiupel, Matti Shapiro, Erik bioRxiv Article Biomedical implants remain an important clinical tool for restoring patient mobility and quality of life after trauma. While polymers are often used for devices, their degradation profile remains difficult to determine post-implantation. CT monitoring could be a powerful tool for in situ monitoring of devices, but polymers require the introduction of radiopaque contrast agents, like nanoparticles, to be distinguishable from native tissue. As device function is mediated by the immune system, use of radiopaque nanoparticles for serial monitoring therefore requires a minimal impact on inflammatory response. Radiopaque polymer composites were produced by incorporating 0-20wt% TaO(x) nanoparticles into synthetic polymers: polycaprolactone (PCL) and poly(lactide-co-glycolide) (PLGA). In vitro inflammatory response to TaO(x) was determined by monitoring mouse bone marrow derived macrophages on composite films. Nanoparticle addition stimulated only a slight inflammatory reaction, namely increased TNFα secretion, mediated by changes to the polymer matrix properties. When devices (PLGA 50:50 + 20wt% TaO(x)) were implanted subcutaneously in a mouse model of chronic inflammation, no changes to device degradation were noted although macrophage number was increased over 12 weeks. Serial CT monitoring of devices post-implantation provided a detailed timeline of device structural collapse, with no burst release of the nanoparticles from the implant. Changes to the device were not significantly altered with monitoring, nor was the immune system ablated when checked via blood cell count and histology. Thus, polymer devices incorporating radiopaque TaO(x) NPs can be used for in situ CT monitoring, and can be readily combined with multiple medical imaging techniques, for a truly dynamic view biomaterials interaction with tissues throughout regeneration, paving the way for a more structured approach to biomedical device design. Cold Spring Harbor Laboratory 2023-10-30 /pmc/articles/PMC10634892/ /pubmed/37961412 http://dx.doi.org/10.1101/2023.10.26.564238 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Pawelec, Kendell M.
Hix, Jeremy M.L.
Troia, Arianna
Kiupel, Matti
Shapiro, Erik
In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation
title In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation
title_full In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation
title_fullStr In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation
title_full_unstemmed In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation
title_short In vivo Biomedical Imaging of Immune Tolerant, Radiopaque Nanoparticle-Embedded Polymeric Device Degradation
title_sort in vivo biomedical imaging of immune tolerant, radiopaque nanoparticle-embedded polymeric device degradation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634892/
https://www.ncbi.nlm.nih.gov/pubmed/37961412
http://dx.doi.org/10.1101/2023.10.26.564238
work_keys_str_mv AT paweleckendellm invivobiomedicalimagingofimmunetolerantradiopaquenanoparticleembeddedpolymericdevicedegradation
AT hixjeremyml invivobiomedicalimagingofimmunetolerantradiopaquenanoparticleembeddedpolymericdevicedegradation
AT troiaarianna invivobiomedicalimagingofimmunetolerantradiopaquenanoparticleembeddedpolymericdevicedegradation
AT kiupelmatti invivobiomedicalimagingofimmunetolerantradiopaquenanoparticleembeddedpolymericdevicedegradation
AT shapiroerik invivobiomedicalimagingofimmunetolerantradiopaquenanoparticleembeddedpolymericdevicedegradation